Early vs late cardiac surgery in patients with native valve endocarditis-United States Nationwide Inpatient database

J Card Surg. 2020 Oct;35(10):2611-2617. doi: 10.1111/jocs.14854. Epub 2020 Jul 27.

Abstract

Objective: Although the standard treatment of infective endocarditis (IE) is antimicrobial therapy, surgical intervention is required in some cases. However, the optimal timing of surgery remains unclear. Hence, we conducted a population-based analysis using the National Inpatient Sample (NIS) database to assess the outcomes of early versus late surgery in patients with native valve IE.

Methods: We queried the NIS database for all hospitalized patients between 2006 and 2016 with a primary diagnosis of IE who had cardiac surgery. We stratified surgery as early ≤7 or late >7 days of admission. Multivariable logistic regression models were used to assess in-hospital mortality and postoperative complications. Length of stay (LOS) and total hospital cost (HC) were evaluated using multivariable log-normal regression models.

Results: A total of 13 056 patients (57.6% in the early group and 42.4% in the late group) were included. The in-hospital mortality rate in the early group was 5.0% compared to 5.4% in the late intervention group (adjusted odds ratio, 1.20, 95% confidence interval [CI] 0.79-1.81). Overall median LOS was reduced in the early group by 48.2% (95% CI, 46.5%-49.9%, 12.4 days in the early group and 25.9 days in late group), as well as HC which was reduced in the early group by 28.3% (95% CI, 26.0%-30.6%).

Conclusion: Among patients with native valve IE who needed cardiac surgery, the time of surgical intervention did not affect the in-hospital mortality. However, early surgery was associated with significantly shorter LOS and lower HC.

Keywords: infective endocarditis; mortality; surgery.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Databases, Factual*
  • Endocarditis / economics
  • Endocarditis / mortality*
  • Endocarditis / surgery*
  • Female
  • Heart Valve Diseases / economics
  • Heart Valve Diseases / mortality*
  • Heart Valve Diseases / surgery*
  • Hospital Mortality
  • Hospitalization / economics
  • Humans
  • Inpatients*
  • Length of Stay
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Time Factors
  • Treatment Outcome
  • United States
  • Young Adult